US4386072A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
Assignee: Efamol Ltd
•
Filing: 1982-02-03
•
Granted: 1983-05-31
•
Expires: 2002-02-03
Abstract
Abstract A method for the treatment or prophylaxis of disorders of inflammation and immunity and disorders associated with smooth muscle spasm, by administering dihomo-γ-linolenic acid or a bioprecursor thereof conjointly with a physiologically acceptable lithium salt. Vitamin E and related tocopherols may optionally be also administered.
Inventors
- 👤 David F. Horrobin
- 👤 Julian Lieb
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 19:40
CPC Classifications
A; A61; A61K; A61K33/00; A61K31/00; A61K31/185; A61K31/19; A61K31/20
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
49 words
A method for the treatment and/or prophylaxis of disorders of inflammation and immunity and disorders associated with smooth muscle spasm in a subject, which method comprises administering to the subject an effective amount therefor of dihomo-γ-linolenic acid, γ-linolenic acid or linoleic acid conjointly with a physiologically acceptable lithium salt.
Claim 2
Independent Claim
49 words
A method for the treatment and/or prophylaxis of disorders of inflammation and immunity and disorders associated with smooth muscle spasm in a subject, which method comprises administering to the subject an effective amount therefor of dihomo-γ-linolenic acid, γ-linolenic acid or linoleic acid conjointly with a physiologically acceptable lithium salt.
Claim 3
Dependent Claim
25 words
A method according to claim 1 wherein at least one compound selected from the group consisting of vitamin E and related tocopherols is additionally administered.
Claim 4
Dependent Claim
41 words
A pharmaceutical composition adapted for oral administration which comprises effective amounts of at least one compound selected from the group consisting of dihomo-γ-linolenic acid, γ-linolenic acid and linoleic acid, together with effective amounts of at least one physiologically acceptable lithium salt.
Claim 5
Dependent Claim
41 words
A pharmaceutical composition adapted for oral administration which comprises effective amounts of at least one compound selected from the group consisting of dihomo-γ-linolenic acid, γ-linolenic acid and linoleic acid, together with effective amounts of at least one physiologically acceptable lithium salt.
Claim 6
Dependent Claim
26 words
A composition according to claim 3 additionally containing effective amounts of at least one compound selected from the group consisting of vitamin E and related tocopherols.
References Cited (Backward Citations)
US3993775A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-05-30 | 1986-11-29 | 1987-05-31 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-05-30 | 1990-11-29 | 1991-05-31 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-05-30 | 1994-11-29 | 1995-05-31 | $7700.00 | Window Closed / Lapsed |